E Fund Management Co. Ltd. Takes Position in CME Group Inc. (NASDAQ:CME)

E Fund Management Co. Ltd. bought a new stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) during the fourth quarter, Holdings Channel reports. The fund bought 892 shares of the financial services provider’s stock, valued at approximately $207,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Geode Capital Management LLC boosted its holdings in CME Group by 1.8% in the 3rd quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock worth $1,823,964,000 after buying an additional 142,692 shares during the last quarter. Raymond James Financial Inc. purchased a new position in shares of CME Group in the fourth quarter valued at approximately $871,063,000. Janus Henderson Group PLC boosted its stake in shares of CME Group by 17.8% in the third quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider’s stock worth $554,707,000 after acquiring an additional 380,071 shares during the last quarter. Capital Wealth Planning LLC increased its position in shares of CME Group by 69.2% during the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider’s stock worth $565,671,000 after purchasing an additional 996,498 shares in the last quarter. Finally, Franklin Resources Inc. raised its stake in CME Group by 70.4% in the 3rd quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock valued at $544,157,000 after purchasing an additional 1,003,119 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling

In related news, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the transaction, the insider now owns 21,885 shares in the company, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 3,984 shares of the company’s stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now directly owns 27,046 shares in the company, valued at approximately $6,774,211.62. The trade was a 12.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 17,076 shares of company stock valued at $4,271,496. Company insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

CME has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft lowered their target price on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Oppenheimer boosted their price target on shares of CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a research report on Thursday, February 13th. Citigroup downgraded shares of CME Group from a “buy” rating to a “neutral” rating and cut their price objective for the company from $255.00 to $250.00 in a report on Monday, January 6th. Royal Bank of Canada raised their target price on shares of CME Group from $235.00 to $269.00 and gave the stock a “sector perform” rating in a research note on Thursday, February 13th. Finally, Keefe, Bruyette & Woods upped their price target on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a research report on Friday, February 14th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus price target of $235.50.

View Our Latest Report on CME Group

CME Group Price Performance

NASDAQ:CME opened at $254.57 on Monday. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $258.78. The stock’s fifty day moving average is $240.07 and its two-hundred day moving average is $230.85. The company has a market capitalization of $91.74 billion, a P/E ratio of 26.33, a P/E/G ratio of 6.76 and a beta of 0.53. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Equities analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group declared that its board has initiated a share buyback plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s management believes its stock is undervalued.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be issued a $1.25 dividend. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a dividend yield of 1.96%. The ex-dividend date is Friday, March 7th. CME Group’s dividend payout ratio is currently 51.71%.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.